Eris Lifesciences Ltd Stock Price Today (NSE: ERIS)
Fundamental Score
Eris Lifesciences Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Eris Lifesciences Ltd share price today is ₹1354.70, down 1.49% on NSE/BSE as of 31 July 2026. Eris Lifesciences Ltd (ERIS) is a Large-cap company in the Pharmaceuticals sector with a market capitalisation of ₹20.26K (Cr). The 52-week high for ERIS share price is ₹1855.60 and the 52-week low is ₹1200.00. At a P/E ratio of 32.06x, ERIS is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 18.70% and a debt-to-equity ratio of 0.60.
Eris Lifesciences Ltd Share Price Chart — NSE/BSE Historical Performance
Eris Lifesciences Ltd share price chart: -6.34% return over the past month. 52-week high ₹1855.60, 52-week low ₹1200.00.
Eris Lifesciences Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹1382.10 | ₹1387.90 | ₹1345.00 | ₹1354.70 | 1.46L (Cr) | |
| ₹1420.00 | ₹1420.00 | ₹1346.00 | ₹1375.20 | 2.29L (Cr) | |
| ₹1397.00 | ₹1441.90 | ₹1383.90 | ₹1426.50 | 3.69L (Cr) | |
| ₹1403.50 | ₹1412.90 | ₹1383.00 | ₹1390.80 | 52.64K (Cr) | |
| ₹1399.00 | ₹1414.00 | ₹1386.10 | ₹1403.50 | 38.23K (Cr) | |
| ₹1375.10 | ₹1409.00 | ₹1373.00 | ₹1400.60 | 39.62K (Cr) | |
| ₹1430.10 | ₹1454.80 | ₹1390.00 | ₹1395.60 | 79.58K (Cr) | |
| ₹1464.00 | ₹1475.00 | ₹1445.00 | ₹1470.00 | 79.15K (Cr) | |
| ₹1455.40 | ₹1472.80 | ₹1432.10 | ₹1463.30 | 99.16K (Cr) | |
| ₹1495.90 | ₹1495.90 | ₹1441.20 | ₹1455.40 | 77.04K (Cr) |
Eris Lifesciences Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1448.40 | ₹1499.00 | ₹1345.00 | ₹1354.70 | -6.47% | |
| ₹1400.00 | ₹1488.00 | ₹1337.60 | ₹1433.50 | +2.39% | |
| ₹1322.90 | ₹1530.00 | ₹1322.00 | ₹1399.00 | +5.75% | |
| ₹1312.90 | ₹1478.00 | ₹1200.00 | ₹1322.90 | +0.76% | |
| ₹1341.10 | ₹1375.90 | ₹1236.00 | ₹1297.20 | -3.27% | |
| ₹1375.00 | ₹1529.00 | ₹1316.20 | ₹1358.30 | -1.21% | |
| ₹1517.00 | ₹1563.00 | ₹1301.20 | ₹1375.50 | -9.33% | |
| ₹1586.00 | ₹1740.00 | ₹1469.10 | ₹1505.60 | -5.07% | |
| ₹1602.00 | ₹1700.00 | ₹1506.30 | ₹1595.40 | -0.41% | |
| ₹1585.00 | ₹1660.00 | ₹1520.00 | ₹1591.70 | +0.42% | |
| ₹1795.00 | ₹1810.80 | ₹1566.00 | ₹1585.90 | -11.65% | |
| ₹1808.40 | ₹1855.60 | ₹1630.00 | ₹1800.20 | -0.45% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Eris Lifesciences Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Eris Lifesciences Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ERIS across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Return on Equity (18.70%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Strong Operating Margins (34.74%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (200.10%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (20.89% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Cash Generation (₹1216.90 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (53.92%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Strong Institutional Confidence (FII+DII: 26.74%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Risk Factors
0 factors identified
No significant concerns identified in current analysis.
Eris Lifesciences Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Eris Lifesciences Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Eris Lifesciences LtdEris Lifescienc...Selected✓ ERIS • 540596 | 45.4/100 | ₹1354.70₹1355 | ₹20260.37₹20260.37 | 32.06Average 32.1 Average | 18.70%Good 18.70% Good | 14.14%Average 14.14% Average | 0.60Good 0.6 Good | 12.36%Good 12.36% Good | 20.89%Excellent 20.89% Excellent | 0.50% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1990.50₹1991 | ₹468821.49₹468821.49 | 37.73Average 37.7 Average | 15.95%Good 15.95% Good | 20.53%Excellent 20.53% Excellent | 0.06Excellent 0.1 Excellent | 16.75%Excellent 16.75% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 56.3/100 | ₹8056.00₹8056 | ₹193163.97₹193163.97 | 73.64Average 73.6 Average | 16.53%Good 16.53% Good | 21.96%Excellent 21.96% Excellent | 0.00Excellent 0.0 Excellent | 5.71%Good 5.71% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹5122.80₹5123 | ₹169902.02₹169902.02 | 77.52Average 77.5 Average | 27.43%Excellent 27.43% Excellent | 15.19%Good 15.19% Good | 1.79Average 1.8 Average | 12.07%Good 12.07% Good | 11.80%Good 11.80% Good | 0.76% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 40.2/100 | ₹1473.20₹1473 | ₹116131.81₹116131.81 | 30.51Average 30.5 Average | 11.60%Average 11.60% Average | 15.49%Good 15.49% Good | 0.02Excellent 0.0 Excellent | 9.94%Good 9.94% Good | 8.01%Good 8.01% Good | 0.90% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1078.30₹1078 | ₹115375.77₹115375.77 | 21.26Average 21.3 Average | 21.25%Excellent 21.25% Excellent | 21.14%Excellent 21.14% Excellent | 0.46Excellent 0.5 Excellent | 18.77%Excellent 18.77% Excellent | 12.45%Good 12.45% Good | 0.09% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 83.4/100 | ₹2415.00₹2415 | ₹113976.53₹113976.53 | 20.04Average 20.0 Average | 28.68%Excellent 28.68% Excellent | 29.93%Excellent 29.93% Excellent | 0.29Excellent 0.3 Excellent | 37.02%Excellent 37.02% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2469.60₹2470 | ₹105053.91₹105053.91 | 52.29Average 52.3 Average | 13.12%Average 13.12% Average | 13.50%Average 13.50% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 41/100 | ₹1148.10₹1148 | ₹102660.46₹102660.46 | 25.62Average 25.6 Average | 11.22%Average 11.22% Average | 13.04%Average 13.04% Average | 0.20Excellent 0.2 Excellent | 15.44%Excellent 15.44% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1580.20₹1580 | ₹90035.87₹90035.87 | 25.38Average 25.4 Average | 10.06%Average 10.06% Average | 12.80%Average 12.80% Average | 0.21Excellent 0.2 Excellent | 0.80%Average 0.80% Average | 6.32%Good 6.32% Good | 0.26% |
Laurus Labs LtdLaurus Labs Ltd... LAURUSLABS • 540222 | 34.1/100 | ₹1816.20₹1816 | ₹84016.75₹84016.75 | 93.94Average 93.9 Average | 18.30%Good 18.30% Good | 17.76%Good 17.76% Good | 0.48Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price468821.49 Cr
- Divis Laboratories Ltd share price193163.97 Cr
- Torrent Pharmaceuticals Ltd share price169902.02 Cr
- Cipla Ltd share price116131.81 Cr
- Zydus Lifesciences Ltd share price115375.77 Cr
Eris Lifesciences Ltd PE Ratio History
Historical price-to-earnings ratio for ERIS — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹25.81 | ₹1505.60 | 58.3x |
| FY 2024 | ₹28.79 | ₹1373.70 | 47.7x |
| FY 2023 | ₹28.07 | ₹910.00 | 32.4x |
| FY 2022 | ₹29.88 | ₹647.25 | 21.7x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Eris Lifesciences Ltd Dividend History
Annual cash dividends paid by ERIS — dividend yield 0.50%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹100.05 Cr |
| FY 2023 | ₹99.91 Cr |
| FY 2022 | ₹81.62 Cr |
| FY 2021 | ₹74.68 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Eris Lifesciences Ltd Quarterly Performance
Latest quarterly metrics for ERIS — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
7.27%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
200.10%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
20.89%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
12.36%
Compounded annual net profit growth over 5 years
Eris Lifesciences Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ERIS — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Eris Lifesciences Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Eris Lifesciences Ltd (ERIS) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Eris Lifesciences Ltd
About ERIS (Eris Lifesciences Ltd)
Eris Lifesciences Ltd (ERIS) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a curr...ent market capitalisation of ₹20.26K (Cr). Eris Lifesciences Ltd has delivered a Return on Equity (ROE) of 18.70% and a ROCE of 14.14%. The debt-to-equity ratio stands at 0.60, reflecting the company's capital structure. Investors tracking ERIS share price can monitor key metrics including P/E ratio, promoter holding of 53.92%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
ERIS Share Price: Frequently Asked Questions
What is the current share price of Eris Lifesciences Ltd?
Eris Lifesciences Ltd (ERIS) trades at ₹1354.70 on NSE and BSE. Market cap ₹20.26K (Cr). Educational data only.
What is the P/E ratio of Eris Lifesciences Ltd?
Eris Lifesciences Ltd has a P/E of 32.06x vs industry average 34.89x.
What is the Bull Run score for Eris Lifesciences Ltd?
Eris Lifesciences Ltd has a Bull Run score of 45.4/100 based on 25+ financial parameters.
Does Eris Lifesciences Ltd pay dividends?
Eris Lifesciences Ltd has a dividend yield of 0.50%. Past dividends don't guarantee future payments.
What is the ROE of Eris Lifesciences Ltd?
Eris Lifesciences Ltd has ROE of 18.70%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Eris Lifesciences Ltd?
Eris Lifesciences Ltd has debt-to-equity of 0.60.
Is Eris Lifesciences Ltd a good investment?
Bull Run gives Eris Lifesciences Ltd a score of 45.4/100. This is not investment advice — consult a SEBI-registered advisor.